SMO and prostate carcinoma: Elevated Hh pathway activity is associated with various cancers, including prostate cancer.[44] The Hh signal is typically inhibited by the tumor suppressor Ptch1, which suppresses the function of the proto‐oncogene Smo, a central activator of this pathway.